What is the market doing?
What the tape says about ANIP
ANI Pharmaceuticals, Inc. is +8.0% over the past year while the S&P 500 is +23%: 15 points behind the market.
+8.0%
1-year return · S&P 500 +23%
- vs 200-day average
- −7.2%
vs 200-day average · below trend, but not far
- RSI (14)
- 30
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- −25%
Below its 52-week high
Details›
- Last close2026-08-26
- $74.57
- 1 monthS&P 500 +3.7%
- −5.1%
- 1 yearS&P 500 +23%
- +8.0%
- 5 yearsS&P 500 +87%
- +123%
- vs 50-day average$78.95
- −5.5%
- 52-week high
- $98.81
- 52-week low
- $70.49
- Annualised volatility
- 37%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$7.2M
| Year | Return |
|---|---|
| 2026 (year to date) | −5.5% |
| 2025 | +43% |
| 2024 | +0.25% |
| 2023 | +37% |
| 2022 | −13% |
| 2021 | +59% |
| 2020 | −53% |
| 2019 | +37% |
| 2018 | −30% |
| 2017 | +6.3% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +3.2% |
| Feb | 10 | 4 of 10 | −0.18% |
| Mar | 10 | 5 of 10 | −2.5% |
| Apr | 10 | 6 of 10 | +0.67% |
| May | 10 | 4 of 10 | −3.1% |
| Jun | 10 | 8 of 10 | +6.9% |
| Jul | 11 | 6 of 11 | +1.3% |
| Aug | 11 | 4 of 11 | +2.1% |
| Sep | 10 | 4 of 10 | −0.42% |
| Oct | 10 | 5 of 10 | +1.9% |
| Nov | 10 | 5 of 10 | +2.4% |
| Dec | 10 | 4 of 10 | −1.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #10 of 28 by Smart Score